 |
bevacizumab |
|---|---|
| Trade Name | Avastin |
| Orphan Indication | In combination with a platinum and 5-FU or capecitabine for the treatment of stomach cancer |
| USA Market Approval | USA |
| USA Designation Date | 2009-11-20 00:00:00 |
| Sponsor | Genentech, Inc.;1 DNA Way;South San Francisco, California, 94080 |
